Vicarious Surgical (RBOT) Non-Current Deffered Revenue (2020 - 2021)
Vicarious Surgical's (RBOT) quarterly Non-Current Deffered Revenue came in at $1.6 million in Q4 2021, up 2712.07% year-on-year from $58000.0 in Q4 2020, and up 11.18% on a QoQ basis from $1.5 million in Q3 2021.
Vicarious Surgical (RBOT) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has 2 years of Non-Current Deffered Revenue data on file, last reported at $1.6 million in Q4 2021.
- On a quarterly basis, Non-Current Deffered Revenue rose 2712.07% year-over-year to $1.6 million in Q4 2021; TTM through Dec 2021 was $1.6 million, a 2712.07% increase from a year earlier, with the FY2021 full-year figure at $1.6 million, up 2712.07% from the prior year.
- Non-Current Deffered Revenue for Q4 2021 stood at $1.6 million, up from $1.5 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for RBOT reached as high as $12.1 million in Q3 2020 and fell as low as $58000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 12.08 Mn |
| Mar 31, 2021 | 12.08 Mn |
| Dec 31, 2020 | 58,000.00 |
| Sep 30, 2020 | 12.08 Mn |